SynthesisFrontiers in endocrinology2022

Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis.

Dongmei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.